Grants per year
Search results
-
Active
Prot #M19-044: A Phase 3, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Efficacy, Safety, and Tolerability of Upadacitinib in Adult and Adolescent Subjects with Non-Segmental Vitiligo Who Are Eligible for Systemic Therapy
Kundu, R. V. (PD/PI)
6/27/24 → 6/27/27
Project: Research project
-
Finished
Understanding Skin of Color and Improving Outcomes in Patients of Color
Kundu, R. V. (PD/PI), Paller, A. (Other), Rangel, S. M. (Other) & Riley, J. M. (Other)
7/1/22 → 6/30/23
Project: Research project
-
Prot#INCB 18424-308 "A Double-Blind, Vehicle-Controlled, Randomized Withdrawal and Treatment Extension Study to Assess the Long-Term Efficacy and Safety of Ruxolitinib Cream in Participants With Vitiligo"
Kundu, R. V. (PD/PI)
Premier Research International, LLC, Incyte Corporation
7/21/21 → 7/21/24
Project: Research project
-
Prot #INCB 18424-306: A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream Followed by an Extension Period in Participants With Vitiligo
Kundu, R. V. (PD/PI)
Premier Research International, LLC, Incyte Corporation
8/5/19 → 6/1/23
Project: Research project
-
Prot #MRG201-30-201: A Phase 2, Double-blind, Placebo-Controlled Study to Investigate the Efficacy, Safety and Tolerability of MRG-201 Following Intradermal Injection in Subjects with a History of Keloids
Kundu, R. V. (PD/PI)
Novella Clinical, LLC, miRagen Therapeutics, Inc.
6/26/18 → 6/26/21
Project: Research project
-
Prot #RVK 09062016: Gene Expression and Biomarker Profiling of Keloid Skin
Kundu, R. V. (PD/PI)
Regeneron Pharmaceuticals, Inc.
6/28/17 → 8/31/22
Project: Research project
-
Prot #INCB 18424-211: A Randomized, Double-Blind, Dose-Ranging Study of INCB018424 Phosphate Cream in Subjects With Vitiligo
Kundu, R. V. (PD/PI)
Premier Research International, LLC, Incyte Corporation
6/16/17 → 8/31/22
Project: Research project
-
Effectiveness of a knowledge-based intervention on quality of life for patients with cutaneous lupus erythematosus
Kundu, R. V. (PD/PI)
4/27/12 → 9/27/12
Project: Research project
-
Development and Validation of a Health-Related Quality of Life Instrument for Vitiligo
Kundu, R. V. (PD/PI) & West, D. P. (Co-Investigator)
2/1/10 → 1/31/13
Project: Research project
-
Assessment and Development of Educational Tools for the Detection of Signs of Melanoma within Minority Patients
Kundu, R. V. (PD/PI)
5/15/08 → 10/15/08
Project: Research project
-
Assessment and Development of Educational Tools for the Detection of Signs of Melanoma within Minority Patients
Kundu, R. V. (PD/PI)
5/15/08 → 10/15/08
Project: Research project
-
Prot# 03-4OHT-01: A Randomized, Double-Blind, Placebo Controlled Trial of 4-Hydroxy Tamoxifen Gel in Women with Symptomatic Keloid Scars
Kundu, R. V. (PD/PI) & West, D. P. (Co-PD/PI)
ASCEND Therapeutics, Inc., Besins International U.S. Inc.
11/8/04 → 7/31/07
Project: Research project
-
Prot# 03-4OHT-01: A Randomized, Double-Blind, Placebo Controlled Trial of 4-Hydroxy Tamoxifen Gel in Women with Symptomatic Keloid Scars
Kundu, R. V. (PD/PI) & West, D. P. (Co-PD/PI)
ASCEND Therapeutics, Inc., Besins International U.S. Inc.
11/8/04 → 7/31/07
Project: Research project